학술논문
Serum immunoglobulin G level reduction is a predictor of short‐term improvement in patients with myasthenia gravis undergoing plasmapheresis.
Document Type
Article
Author
Source
Therapeutic Apheresis & Dialysis; Feb2024, Vol. 28 Issue 1, p131-140, 10p
Subject
Language
ISSN
17449979
Abstract
Copyright of Therapeutic Apheresis & Dialysis is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)